Some studies concluded that IL-4 plays a pathogenic role in the development of APAP-induced hepatotoxicity [185], but other studies have shown that transgenic C57BL/6 mice lacking IL-4 or IL-13 have increased sensitivity to AILI [187, 188]. The gene discussed is IL4; the disease is hepatotoxicity.